First Treatment for Breast Cancer with certain Inherited Gene Mutation
Scientific Journal of Genetics and Gene Therapy · 2018
DOI: 10.17352/sjggt.000013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Journal of Genetics and Gene Therapy, 2018. Verfasst von Naseer Sulaiman. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The U.S. Food and Drug Administration approved use of Lynparza (olaparib tablets) treat certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer.
Zitieren
APA
Sulaiman, N. (2018). First Treatment for Breast Cancer with certain Inherited Gene Mutation. Scientific Journal of Genetics and Gene Therapy. https://doi.org/10.17352/sjggt.000013
Vancouver
Sulaiman N. First Treatment for Breast Cancer with certain Inherited Gene Mutation. Scientific Journal of Genetics and Gene Therapy. 2018. doi:10.17352/sjggt.000013
BibTeX
@article{Sulaiman2018,
author = {Sulaiman, Naseer},
title = {First Treatment for Breast Cancer with certain Inherited Gene Mutation},
journal = {Scientific Journal of Genetics and Gene Therapy},
year = {2018},
doi = {10.17352/sjggt.000013}
}
EUVIMED